Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$151.61
▲ $2.11 (+1.41%) today
Markets open · 1:13pm ET

MRK Coverage

Page 70
1:52pm ET
Investing

S&P 500 Pushes Toward 25% Gain Since March 9th

At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March 9th. The bank stocks continue an extraordinary run over that period. Citigroup…

Douglas A. McIntyre
5:25am ET
Health and Healthcare

Merck’s (MRK) New Merger, Another Way To Save Money

Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1  billion. In reality, Merck is making an acquisition. Its shares will be the currency to…

MRK
Douglas A. McIntyre
8:57am ET
Health and Healthcare

Merck Bares All In Pipeline Presentation (MRK)

Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week.  Merck plans to emerge next year and into the next decade leaner and…

MRK
Douglas A. McIntyre
9:06am ET
Jobs

DJIA Losing 3 Trifecta (T, DD, MRK)

It is easy to get pumped up about overseas rate cuts, but there is cautionary data from at least three DJIA components.  Wal-Mart is the economic trade-down so that win in retail…

DD MRK T
Douglas A. McIntyre
7:29am ET
Health and Healthcare

Merck (MRK): People Won’t Even Buy Drugs

So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock is off before the open. According to Reuters, "Merck said it expected…

MRK
Douglas A. McIntyre
9:24am ET
Health and Healthcare

Biotech Implosion: Dynavax (DVAX)

Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today.  The company gave an update on an FDA clinical hold on its investigational vaccine HEPLISAV…

Douglas A. McIntyre